Www.global-campaign.org What Do We Mean by Community?

Slides:



Advertisements
Similar presentations
National Agenda for CSO Capacity Development Yin Soriya, Ph.D.
Advertisements

Global Prevention Research Advocacy Partnerships Good Participatory Practice Initiative In November 2007, UNAIDS and AVAC published Good Participatory.
Module 5 Representivity. What’s in Module 5  Who has how much voice?  For SP practitioners: ensuring representativity  For SP participants: how to.
We need user-led research more now than ever before…
Stakeholder Engagement and Good Participatory Practices for Global Clinical Trials: Developing Tools and Models for the 21st Century Kathleen M. MacQueen,
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials Second Edition 2011.
HIV Prevention Trials-Creating Effective Partnerships: the West and Central Africa Experience Dr Baafuor Opoku SAVVY Project, Kumasi, Ghana.
National Working Group on Microbicides Microbicides advocacy Paramita Kundu & Ananthy Thambinayagam Global Campaign for Microbicides, PATH January 2007.
MSP course 2007 Phase 0 – Setting up Kumasi, Ghana 2008 Wageningen International.
Abstract Number: THAE0103 Stepping up National Coordination and Ownership of HIV Programming 24 July 2014  14:30-16:00  Plenary 3 Partners in Change.
Twenty Years Later ICPD Beyond 2014 A Briefing on the ICPD Beyond 2014 Review Process 2012.
University of Wisconsin - Extension, Cooperative Extension, Program Development and Evaluation Unit 3: Engaging stakeholders.
Forming and Sustaining Community Groups / Community Advisory boards (CWGs/CABs) Presenter: Smangaliso Ntshele Community Mobilization Project Leader, Medical.
Our host country: Female Condoms and Microbicides in India Paramita Kundu Global Campaign for Microbicides.
Strategies for Community Mobilization
AIDS 2010 Societies Tackling AIDS through Rights Presented by Christy Abraham International Theme Manager HIV & AIDS ActionAid International.
Preparing for and Disseminating Study Results. Overview This session will cover how to: Develop and implement a dissemination plan Correctly time the.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Making the Ethical Feasible: Assuring future access to care to those who sero-convert in microbicide trials Anna Forbes, MSS XVI.
Global Campaign for Microbicides Rebekah Webb, European Coordinator
Illegal Logging and FLEGT - Elements of an IUCN Response Tim Christophersen, IUCN – The World Conservation Union June 22, 2005.
COMMUNITY EDUCATION AFTER INTEGRATED CAMPAIGNS PROMOTING ITN USE IN GHANA Mark Young/Melanie Renshaw Ghana/ NYHQ.
Community Engagement in clinical trials Projet Ubuzima experience By Marie Michèle UMULISA Community Outreach & Recruitment Manager, Projet Ubuzima.
CPTR Key Accomplishments: Research Resources Group October 3, 2012.
What Makes a Successful Trial? MorenikeUkpong Nigeria HIV Vaccine and Microbicide Advocacy Group.
Evolution in Community Involvement: The Changing Landscape Lori Heise Global Campaign for Microbicides.
Working Group 2 NGO and Civil Society Global WOPs Alliance Foundation Meeting.
HIV AND HOUSING WORKSHOP : JOHANNESBURG 14—19 SEPTEMBER 2014 CONGEH PRESENTATION ON ADVOCACY AND NETWORK.
Good Participatory Practice UNAIDS & AVAC Document Pauline Irungu Global Campaign for Microbicides.
Department for International Development Participatory Rights Assessment Methodologies (PRAMs)
Stakeholder Analysis.
Learning journey Part 1: Welcome and introduction Part 2: Concepts, evidence, and good practice: Addressing gender-based violence and engaging men and.
MDP301 An international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5.
Introduction to Research Ethics Africa RWG Workshop 21 May 2003 Stella Kirkendale Wayne Wilson.
Committee for Women and Family Affairs at the Government of Tajikistan: Addressing HIV based violence, stigma and discrimination in communities.
Global Partnership on Disability and Development What is the GPDD? Presentation to JICA Group Training Course HIV/AIDS Section Judith Heumann, Lead Consultant,
Bridging the gap between research and policy making? Ajoy Datta Foundation for the Future, Dead Sea, Jordan Civil Society Partnerships Programme
Communications During a Clinical Trial. Overview This session will cover how to: Announce your trial Maintain good communications Communicate with key.
Building a Microbicides Movement Partnerships in advocacy and science. Global Campaign for Microbicides.
Best practices guidance in conducting HIV research with gay, bisexual, and other men who have sex with men (MSM) in rights constrained environments.
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials 2011, Second Edition.
TRUE PATIENT & PARTNER ENGAGEMENT HOW IS IT DONE?.
Microbicides Advocacy at the EU level Rebekah Webb European Coordinator, GCM.
Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Participant Accrual Plans MTN-003 Study-Specific Training.
HOW ARE MDP PREPARING COMMUNITIES AT TRIAL SITES? MDP301.
HANC and Community Partners Overview November 20, 2007 Michael Petillo, Project Coordinator.
Working Synergistically: Two Possible Mechanisms.
11/3/2011 Exploring How Values, Identity and Gender Influence Evaluator Approach and Role.
Hankins UNAIDS Mexico Aug 6/08 Women and clinical trials: Where have we been and where are we going? ‘Women and clinical trials: where have we been and.
Stakeholder Participation and Analysis.  What is meaningful participation?  What is a stakeholder?  Why stakeholder participation?  What is participation?
4th CAN CBR Conference, Abuja, 28th October 2010
Vaccine Enterprise & Collaboration Bill Snow, Director 19 January 2013 CHVI Afri-Can Forum.
GCM Calendar Events and activities 2006 M2006 UNGASS Toronto.
Impact of Donor-Imposed Requirements and Restrictions on Standard of Care in Microbicide Trials Sean Philpott, PhD, MSBioethics.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
Urban Governance Francis Matita Monitoring and Evaluation Manager.
Country and community preparedness: Community Involvement in Clinical Trials Global Campaign for Microbicides.
1 Organising a participatory process. 2 Objectives  To understand how to organise an inclusive and consultative law or policy- making process  To learn.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
GEF’s Partnership with Civil Society Organizations GEF Expanded Constituency Workshop July 6 – 8, 2011 Dakar, Senegal.
The missing chapter of the MDS Anna Forbes, Deputy Director Delhi, 25 February, 2008.
Civil society strategies on LANGO KEY CONCERNS, ADVOCACY EFFORTS, SUMMARY REPORT OF CASES DOCUMENTATION, WAYS FORWARD MARCH 10, 2016.
2013 | Presentation by DiDiRi Collective. Hivos LOSA | Free2BMe Hivos Southern Africa LGBTI Programme.
GCM Community Involvement Tool Kit Glenburn Lodge, Muldersdrift, South Africa November 27-28, 2007.
SOCIAL ENTERPRISES IN ALBANIA SOCIALNET This project is funded by the European Union.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
Good Participatory Practice (GPP) Guidelines for Biomedical HIV Prevention Trials 2011, Second Edition Note to trainer/presenter: You may use all or.
New Prevention Technologies Workshop Module 4: Who’s Who
What is the role of a CAB in biomedical HIV prevention research in South Africa? CABS are the most common mechanism for engaging communities in research.
Presentation transcript:

What Do We Mean by Community?

Competing & Changing Definitions of Community “…separate and overlapping groups of people who are infected and affected by HIV in various ways” –Good Participatory Practice, UNAIDS/AVAC “ …trial participants, their families and partners, other local stakeholders, and service providers/community groups within the geographic parameters of the clinical trial location. –MDS Civil Society Working Group Report “…the group of people who will participate in or are likely to be affected by or have an influence on the conduct of the research.” –HIV Prevention Trials Network, Community Program FAQs

…Or No Definition At All In addition to many competing definitions, often times people talk about “community” without defining what they mean or who they are specifically referring to.

Locating Community When we talk about community, it is important to frame the discussion in terms of: –Who is included in the particular “community” we are discussing? –And distinguish which “level” we are referring to

“Trial Participants & Study Staff” refers to the women directly participating in the trial, in some instances their partner(s), and study staff working at the trial site.

“Host Community” refers to the individuals living in the area of the trial, their leaders, and community-based organizations that serve or represent them directly. This can also include traditional healers, local radio, and other community structures (including CABs)

“National Stakeholders” describes anyone who has a role to play in the political, scientific, and social enterprise of microbicide development in the larger, national community. It includes political decision-makers, MoH, regulatory bodies, ethical review committees, national NGOs, donors, national media, etc.

“International Civil Society” refers to non-profit, organized, citizen-led movements or groups interested in the goals, process, and outcomes of microbicide research, and/or in the rights of communities or research participants. Civil society includes international or regional NGOs (GCM/UNAIDS), international or media.

Community Education Staff Typically Work in This Arena But need to also think of ways to move beyond the host community into stakeholder and civil society arenas

Whereas NGOs have typically worked in this arena And have recently started to think of ways to also engage with host communities, trial participants and study staff

Locating Community: Real Life Examples Community Mapping NHVMAG Consultation on National SOC Guidelines GPP Process ICASO Community Voices Project